Fundraising FoxSilverArc Private — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Ventyx Biosciencesventyxbio.cominSep 2024SEC filingmedium confidence
San Diego, US
Mark S. Forman(Executive Officer)inMatthew Moore(Executive Officer)inJohn Nuss(Executive Officer)inJigar Choksey(Director)Martin Auster(Executive Officer)inChristopher W. Krueger(Executive Officer)
Board seatSheila Gujrathi· per SEC Form D · $27M raise · filed Sep 2024
Co-investorsNew Science VenturesThird Point VenturesvenBio PartnersWellington ManagementvenBio Global Strategic
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.